Pre- and post-operative voice therapy (PaPOV): Development of an intervention for patients with benign vocal fold lesions.

benign vocal fold lesions intervention development pre- and post-operative voice therapy triangulation voice disorder

Journal

International journal of language & communication disorders
ISSN: 1460-6984
Titre abrégé: Int J Lang Commun Disord
Pays: United States
ID NLM: 9803709

Informations de publication

Date de publication:
01 2023
Historique:
received: 24 11 2021
accepted: 28 06 2022
pubmed: 2 9 2022
medline: 20 1 2023
entrez: 1 9 2022
Statut: ppublish

Résumé

Pre- and post-operative voice therapy may improve voice and quality-of-life outcomes for patients undergoing phonosurgery to remove benign vocal fold lesions (BVFLs). However, what constitutes voice therapy in this population is poorly described, resulting in a poor evidence base, lack of clinical guidelines and unwarranted variation in management. In order to develop the evidence base, a robust, iterative process of intervention development work should precede feasibility testing and effectiveness studies. Guidance for developing complex interventions, drawing on evidence, theory and modelling, was used to inform the development of a pre- and post-operative voice therapy intervention entitled 'PaPOV'. Data from four sources of evidence were synthesized using a published triangulation protocol. Data from a systematic review, national survey of current practice, expert interview study, and patient and public involvement conversations were used to populate a triangulation matrix, outlining components of a PaPOV. Data were coded to reflect areas of agreement, dissonance and silence with each component of the intervention. Based on this evidence, an assessment of convergence for each intervention component could be made. In total, 61 components of the PaPOV intervention were explored. Of these, 27 were categorized as having stability of consensus according to a priori criteria. A total of 34 failed to meet the criteria. This was more frequently due to silence (27) rather than dissonance (seven) in the data. By evidencing areas of agreement and stability of consensus across data sources, the validity of individual findings has been enhanced. Furthermore, the study has exposed specific areas of the intervention that lack consensus and require exploration through further intervention development studies. This systematic triangulation process has contributed to the development of a PaPOV intervention for patients with BVFLs. Exploration of specific components relating to the intervention will allow outstanding questions to be answered in preparation for feasibility testing. What is already known on the subject BVFLs cause dysphonia by preventing vocal fold closure, impacting on vibratory characteristics and increasing compensatory muscle tension. Management for these patients is variable with them being offered phonosurgery, voice therapy, pharmacological management or a combined approach. Pre- and post-operative voice therapy may improve both voice and quality-of-life outcomes. This patient group has unique complexities when considering voice therapy, including surgical preparation, wound healing and epithelial mobilization. What this paper adds to existing knowledge This study uses a robust triangulation process to synthesize current evidence and patient experiences in order to inform the development of a PaPOV. It outlines some of the key components and considerations when delivering pre- and post-operative voice therapy to adults with BVFLs. Furthermore, it serves as a methodological example for intervention development in complex interventions, highlighting key guidance and recommended processes for developing and evaluating complex interventions. What are the potential or actual clinical implications of this work? The 61 components discussed as potential 'ingredients' for a PaPOV enable clinicians to reflect on key considerations when planning and delivering voice therapy to adults with BVFLs. This study highlights the pitfalls both clinically and in research of failing to describe interventions adequately and the benefits of using accurate, specific and agreed terminology in clinical practice, such as that outlined in the Rehabilitation Treatment Specification System (TRSS).

Sections du résumé

BACKGROUND
Pre- and post-operative voice therapy may improve voice and quality-of-life outcomes for patients undergoing phonosurgery to remove benign vocal fold lesions (BVFLs). However, what constitutes voice therapy in this population is poorly described, resulting in a poor evidence base, lack of clinical guidelines and unwarranted variation in management. In order to develop the evidence base, a robust, iterative process of intervention development work should precede feasibility testing and effectiveness studies.
METHODS & PROCEDURES
Guidance for developing complex interventions, drawing on evidence, theory and modelling, was used to inform the development of a pre- and post-operative voice therapy intervention entitled 'PaPOV'. Data from four sources of evidence were synthesized using a published triangulation protocol. Data from a systematic review, national survey of current practice, expert interview study, and patient and public involvement conversations were used to populate a triangulation matrix, outlining components of a PaPOV. Data were coded to reflect areas of agreement, dissonance and silence with each component of the intervention. Based on this evidence, an assessment of convergence for each intervention component could be made.
OUTCOMES & RESULTS
In total, 61 components of the PaPOV intervention were explored. Of these, 27 were categorized as having stability of consensus according to a priori criteria. A total of 34 failed to meet the criteria. This was more frequently due to silence (27) rather than dissonance (seven) in the data. By evidencing areas of agreement and stability of consensus across data sources, the validity of individual findings has been enhanced. Furthermore, the study has exposed specific areas of the intervention that lack consensus and require exploration through further intervention development studies.
CONCLUSIONS & IMPLICATIONS
This systematic triangulation process has contributed to the development of a PaPOV intervention for patients with BVFLs. Exploration of specific components relating to the intervention will allow outstanding questions to be answered in preparation for feasibility testing.
WHAT THIS PAPER ADDS
What is already known on the subject BVFLs cause dysphonia by preventing vocal fold closure, impacting on vibratory characteristics and increasing compensatory muscle tension. Management for these patients is variable with them being offered phonosurgery, voice therapy, pharmacological management or a combined approach. Pre- and post-operative voice therapy may improve both voice and quality-of-life outcomes. This patient group has unique complexities when considering voice therapy, including surgical preparation, wound healing and epithelial mobilization. What this paper adds to existing knowledge This study uses a robust triangulation process to synthesize current evidence and patient experiences in order to inform the development of a PaPOV. It outlines some of the key components and considerations when delivering pre- and post-operative voice therapy to adults with BVFLs. Furthermore, it serves as a methodological example for intervention development in complex interventions, highlighting key guidance and recommended processes for developing and evaluating complex interventions. What are the potential or actual clinical implications of this work? The 61 components discussed as potential 'ingredients' for a PaPOV enable clinicians to reflect on key considerations when planning and delivering voice therapy to adults with BVFLs. This study highlights the pitfalls both clinically and in research of failing to describe interventions adequately and the benefits of using accurate, specific and agreed terminology in clinical practice, such as that outlined in the Rehabilitation Treatment Specification System (TRSS).

Identifiants

pubmed: 36047250
doi: 10.1111/1460-6984.12771
pmc: PMC10086784
doi:

Types de publication

Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-110

Subventions

Organisme : Department of Health
ID : NIHR301570
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. International Journal of Language & Communication Disorders published by John Wiley & Sons Ltd on behalf of Royal College of Speech and Language Therapists.

Références

Evid Based Nurs. 2013 Oct;16(4):98
pubmed: 23943076
Curr Opin Otolaryngol Head Neck Surg. 2011 Jun;19(3):160-4
pubmed: 21330925
J Voice. 2022 Jan;36(1):59-67
pubmed: 32482494
BMC Cancer. 2017 Jan 10;17(1):43
pubmed: 28068939
Trials. 2015 May 03;16:204
pubmed: 25935741
J Voice. 2014 Sep;28(5):652.e31-652.e43
pubmed: 24929936
J Voice. 2017 Jan;31(1):129.e1-129.e7
pubmed: 26776951
Arch Phys Med Rehabil. 2019 Jan;100(1):172-180
pubmed: 30267669
Int J Nurs Stud. 2013 May;50(5):585-7
pubmed: 23159017
PLoS One. 2016 Mar 15;11(3):e0150205
pubmed: 26978655
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006373
pubmed: 17636842
J Voice. 2011 Nov;25(6):647-52
pubmed: 21353465
Am J Phys Med Rehabil. 2003 Aug;82(8):639-52
pubmed: 12872021
J Voice. 2005 Jun;19(2):283-9
pubmed: 15907442
Res Involv Engagem. 2019 Aug 16;5:23
pubmed: 31428458
J Voice. 2008 Sep;22(5):565-80
pubmed: 17509828
Curr Opin Otolaryngol Head Neck Surg. 2010 Dec;18(6):475-80
pubmed: 20861796
Arch Phys Med Rehabil. 2019 Jan;100(1):146-155
pubmed: 30267666
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Pilot Feasibility Stud. 2015 Oct 26;1:36
pubmed: 27965814
Ann Otol Rhinol Laryngol. 2015 May;124(5):407-12
pubmed: 25416241
Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R179-84
pubmed: 18003791
Acta Otorhinolaryngol Ital. 2012 Oct;32(5):304-8
pubmed: 23326009
J Voice. 2012 Nov;26(6):814.e1-13
pubmed: 23177745
Int J Lang Commun Disord. 2023 Jan;58(1):94-110
pubmed: 36047250
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
J Voice. 2017 May;31(3):392.e13-392.e32
pubmed: 27863745
J Voice. 2017 Jan;31(1):97-103
pubmed: 27492336
Arch Phys Med Rehabil. 2021 Mar;102(3):521-531
pubmed: 33065124
J Voice. 2021 Mar 16;:
pubmed: 33741236
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Laryngol Otol. 2013 Nov;127(11):1134-8
pubmed: 24180598
J Voice. 2021 Jul 13;:
pubmed: 34272141
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
J Epidemiol Community Health. 2016 May;70(5):520-5
pubmed: 26573236
Logoped Phoniatr Vocol. 2018 Dec;43(4):143-154
pubmed: 30183437
Qual Health Res. 2006 Mar;16(3):377-94
pubmed: 16449687
J Voice. 2006 Sep;20(3):432-42
pubmed: 16324825
Clin Rehabil. 2018 Jul;32(7):855-864
pubmed: 29436253
Eur Arch Otorhinolaryngol. 2013 Sep;270(9):2491-507
pubmed: 23605306
J Voice. 2010 Jul;24(4):379-87
pubmed: 19660903
J Voice. 2011 Sep;25(5):562-9
pubmed: 20570107
BMJ. 2013 Sep 10;347:f3755
pubmed: 24021722
J Voice. 2017 May;31(3):352-358
pubmed: 27481232
Int Arch Otorhinolaryngol. 2014 Apr;18(2):132-5
pubmed: 25992078
J Voice. 2013 Mar;27(2):210-6
pubmed: 23352061
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD001934
pubmed: 22696326

Auteurs

Anna White (A)

Centre for Rehabilitation and Ageing Research, Academic Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Paul Carding (P)

Faculty of Health and Life Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford, UK.

Vicky Booth (V)

Centre for Rehabilitation and Ageing Research, Academic Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Pip Logan (P)

Centre for Rehabilitation and Ageing Research, Academic Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH